Global Congress on Prostate Cancer - PROSCA 2019

prosca.org

 

Metastatic Hormone-Sensitive Prostate Cancer
14:51

Global Congress on Prostate Cancer - PROSCA 2019

Local Therapy of the Primary in Metastatic Disease: RT Should Be Added to SoC Systemic Therapy in De Novo M1 Low-Burden Prostate Cancer

FEATURING Thomas Zilli
  • 8 views
  • January 10, 2020
25:45

Global Congress on Prostate Cancer - PROSCA 2019

Navigating the Evolving Therapeutic Landscape in M1 Hormone-Sensitive Prostate Cancer: Current ADT Combo Options, Apalutamide/Enzalutamide as Alternative to Abiraterone, Triplet Therapy

FEATURING Karim Fizazi
  • 20 views
  • January 10, 2020
10:27

Global Congress on Prostate Cancer - PROSCA 2019

Case-Based Discussion: 61 y/o Man With De Novo Metastatic Hormone-Sensitive Prostate Cancer - Which Treatment Option to Choose?

FEATURING Mack Roach III, Bertrand Tombal
  • 113 views
  • January 10, 2020
  • 1
21:21

Global Congress on Prostate Cancer - PROSCA 2019

Case-Based Discussion: 66 y/o Man With De Novo Metastatic Hormone-Sensitive Prostate Cancer - Which Treatment Option to Choose?

FEATURING Mack Roach III, Bertrand Tombal
  • 7 views
  • January 10, 2020